AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy

AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy

In the context of future adeno-associated viral (AAV)-based clinical trials for Duchenne myopathy, AAV genome fate in dystrophic muscles is of importance considering the viral capsid immunogenicity that prohibits recurring treatments. We showed that AAV genomes encoding non-therapeutic U7 were lost...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Le Hir, M, Goyenvalle, A, Peccate, C, Précigout, G, Davies, K, Voit, T, Garcia, L, Lorain, S
Natura:	Journal article
Lingua:	English
Pubblicazione:	2013

Documenti analoghi

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
di: Goyenvalle, A, et al.
Pubblicazione: (2010)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
di: Goyenvalle, A, et al.
Pubblicazione: (2011)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
di: Goyenvalle, A, et al.
Pubblicazione: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
di: Goyenvalle, A, et al.
Pubblicazione: (2012)

Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
di: Philippine Aupy, et al.
Pubblicazione: (2020-06-01)

Upgrading U7snRNA To Complete Efficient Rescue of Dystrophin by Exon-Skipping in DMD Patients
di: Goyenvalle, A, et al.
Pubblicazione: (2009)

Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.
di: Goyenvalle, A, et al.
Pubblicazione: (2011)

Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in mice
di: Christina Gedicke‐Hornung, et al.
Pubblicazione: (2013-05-01)

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
di: Goyenvalle, A, et al.
Pubblicazione: (2009)

Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy
di: Goyenvalle, A, et al.
Pubblicazione: (2012)

Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.
di: Goyenvalle, A, et al.
Pubblicazione: (2012)

Rescue of common and rare exon 2 skipping variants of the GAA gene using modified U1 snRNA
di: Paolo Peruzzo, et al.
Pubblicazione: (2025-02-01)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
di: Lu, Q, et al.
Pubblicazione: (2004)

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model
di: Liubov V. Gushchina, et al.
Pubblicazione: (2023-12-01)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
di: Goyenvalle, A, et al.
Pubblicazione: (2010)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
di: Lu, Q, et al.
Pubblicazione: (2003)

Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated DMD exon 2 skipping
di: Tabatha R. Simmons, et al.
Pubblicazione: (2021-06-01)

Exon exchange approach to repair Duchenne dystrophin transcripts.
di: Stéphanie Lorain, et al.
Pubblicazione: (2010-01-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
di: Nicolas Wein, et al.
Pubblicazione: (2022-09-01)

The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery.
di: Eckenfelder, A, et al.
Pubblicazione: (2012)

The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
di: Agathe Eckenfelder, et al.
Pubblicazione: (2012-01-01)

Combined treatment with peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) and AAV-U7 rescues the severe DMD phenotype in mice
di: Forand, A, et al.
Pubblicazione: (2020)

Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice
di: Anne Forand, et al.
Pubblicazione: (2020-06-01)

Exon Skipping in a Dysf-Missense Mutant Mouse Model
di: Jakub Malcher, et al.
Pubblicazione: (2018-12-01)

Nab Escaping AAV Mutants Isolated from Mouse Muscles
di: Zheng Chai, et al.
Pubblicazione: (2018-05-01)

AAV genome modification for efficient AAV production
di: Walaa Asaad, et al.
Pubblicazione: (2023-04-01)

U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes
di: Eric W. Ottesen, et al.
Pubblicazione: (2024-07-01)

A single m6A modification in U6 snRNA diversifies exon sequence at the 5’ splice site
di: Yuma Ishigami, et al.
Pubblicazione: (2021-05-01)

Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
di: Aoki, Y, et al.
Pubblicazione: (2012)

Highly efficient CRISPR/Cas9‐mediated exon skipping for recessive dystrophic epidermolysis bullosa
di: Alex du Rand, et al.
Pubblicazione: (2024-07-01)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
di: Hildegund C. J. Ertl
Pubblicazione: (2021-04-01)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
di: Christopher Chan, et al.
Pubblicazione: (2023-10-01)

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
di: Amel Saoudi, et al.
Pubblicazione: (2023-03-01)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
di: Yokota, T, et al.
Pubblicazione: (2012)

Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa
di: Jeroen Bremer, et al.
Pubblicazione: (2016-01-01)

U1 snRNA associates with TFIIH and regulates transcriptional initiation.
di: Kwek, K, et al.
Pubblicazione: (2002)

Mechanism of U6 snRNA oligouridylation by human TUT1
di: Seisuke Yamashita, et al.
Pubblicazione: (2023-08-01)

Crystal structures of U6 snRNA-specific terminal uridylyltransferase
di: Seisuke Yamashita, et al.
Pubblicazione: (2017-06-01)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
di: Goyenvalle, A, et al.
Pubblicazione: (2010)

AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery
di: Sanna Koponen, et al.
Pubblicazione: (2023-07-01)